3007

COM:PHARMARON

Pharmaron

  • Stock

Last Close

28.38

22/11 07:04

Market Cap

31.15B

Beta: -

Volume Today

28.97M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
38.95M
-
70.18M
80.17%
92.92M
32.41%
106.86M
15.00%
138.93M
30.01%
219.51M
58.00%
480.83M
119.05%
860.75M
79.01%
1.03B
19.35%
average payables
34.16M
-
51.40M
50.45%
76.48M
48.79%
99.93M
30.66%
113.10M
13.18%
154.74M
36.82%
253.52M
63.84%
360.94M
42.37%
409.28M
13.39%
average receivables
260.92M
-
367.15M
40.71%
524.01M
42.72%
661.85M
26.31%
883.46M
33.48%
1.15B
30.02%
1.41B
23.12%
1.95B
37.79%
2.67B
37.01%
book value per share
0.51
-
0.33
34.78%
2.33
597.98%
2.25
3.27%
2.63
16.82%
7.84
198.25%
7.48
4.61%
8.53
14.07%
8.92
4.58%
7.08
20.59%
capex per share
-0.16
-
-0.51
215.26%
-1.39
172.40%
-1.05
24.38%
-0.72
31.28%
-0.76
5.28%
-1.11
45.65%
-1.76
58.88%
-2.49
41.55%
-1.62
35.20%
capex to depreciation
-1.60
-
-4.06
153.73%
-11.36
180.17%
-6.46
43.13%
-3.03
53.15%
-2.38
21.55%
-3.51
47.65%
-4.20
19.84%
-4.24
0.81%
-2.84
32.95%
capex to operating cash flow
-6.75
-
-1.19
82.37%
-4.48
275.96%
-1.69
62.19%
-0.87
48.63%
-0.80
7.53%
-0.80
0.73%
-1.02
27.41%
-1.38
35.38%
-1.02
25.74%
capex to revenue
-0.10
-
-0.23
120.91%
-0.65
182.03%
-0.41
36.92%
-0.22
45.90%
-0.20
8.88%
-0.26
27.62%
-0.28
9.69%
-0.29
2.20%
-0.25
12.95%
cash per share
0.08
-
0.17
112.21%
0.36
106.15%
0.06
83.64%
0.36
524.06%
4.69
1,193.10%
3.25
30.70%
4.29
32.21%
1.90
55.82%
3.79
99.89%
days of inventory on hand
18.57
-
21.33
14.84%
29.12
36.56%
22.06
24.25%
22.39
1.51%
23.71
5.89%
32.02
35.04%
52.09
62.68%
58.50
12.30%
48.31
17.42%
days payables outstanding
16.55
-
18.52
11.88%
19.29
4.18%
21.68
12.36%
20.12
7.19%
17.77
11.65%
21.77
22.51%
24.17
11.01%
22.83
5.57%
19.66
13.88%
days sales outstanding
113.13
-
89.58
20.82%
102.17
14.06%
93.96
8.04%
92.02
2.06%
100.43
9.14%
89.83
10.55%
76.73
14.59%
82.92
8.06%
95.82
15.56%
debt to assets
0.20
-
0.18
11.50%
0.22
23.89%
0.33
49.04%
0.31
7.80%
0.10
65.87%
0.09
15.49%
0.29
225.50%
0.30
3.85%
0.34
15.31%
debt to equity
0.73
-
1.25
71.09%
0.35
71.75%
0.65
83.86%
0.61
6.66%
0.13
78.02%
0.12
11.30%
0.52
340.16%
0.58
11.13%
0.73
25.15%
dividend yield
0.01
-
0.01
6.87%
0.00
39.65%
0.01
259.01%
0.02
23.35%
0.01
63.28%
0.00
66.18%
0.00
79.01%
0.01
97.76%
0.01
7.88%
earnings yield
0.01
-
0.03
251.73%
0.05
59.71%
0.05
11.43%
0.08
47.25%
0.02
69.15%
0.02
23.38%
0.02
20.61%
0.03
15.12%
0.03
21.54%
enterprise value
2.63B
-
2.60B
0.92%
3.87B
48.78%
5.35B
38.16%
5.44B
1.69%
19.28B
254.56%
61.58B
219.46%
76.30B
23.90%
58.22B
23.70%
55.15B
5.28%
enterprise value over ebitda
26.79
-
15.01
43.95%
11.95
20.38%
10.98
8.15%
7.76
29.32%
18.81
142.42%
37.79
100.85%
29.38
22.26%
22.27
24.20%
20.44
8.22%
ev to operating cash flow
216.32
-
11.99
94.46%
16.41
36.90%
9.68
41.01%
7.37
23.83%
20.54
178.51%
37.36
81.87%
37.08
0.75%
27.17
26.72%
19.67
27.59%
ev to sales
3.32
-
2.31
30.57%
2.37
2.70%
2.33
1.58%
1.87
19.78%
5.13
174.44%
12.00
133.80%
10.25
14.55%
5.67
44.68%
4.81
15.11%
free cash flow per share
-0.14
-
-0.08
40.71%
-1.08
1,220.52%
-0.43
60.16%
0.11
125.22%
0.19
70.90%
0.28
51.08%
-0.03
110.44%
-0.68
2,230.41%
-0.04
94.85%
free cash flow yield
-0.03
-
-0.02
40.71%
-0.22
1,220.52%
-0.09
60.16%
0.02
125.22%
0.01
63.45%
0.01
35.32%
-0.00
108.90%
-0.02
3,128.03%
-0.00
91.94%
graham net net
-0.86
-
-1.36
58.65%
-0.50
62.90%
-1.54
205.28%
-1.53
0.92%
3.43
324.86%
1.66
51.71%
-1.25
175.30%
-4.35
248.36%
-1.90
56.33%
graham number
0.69
-
1.05
51.46%
3.49
233.88%
3.63
3.82%
4.76
31.16%
9.87
107.42%
12.90
30.66%
16.39
27.06%
15.28
6.77%
12.00
21.45%
income quality
0.58
-
2.94
408.28%
1.33
54.64%
2.43
82.52%
2.17
10.60%
1.77
18.67%
1.44
18.73%
1.27
11.62%
1.58
24.75%
1.75
10.47%
intangibles to total assets
0.02
-
0.02
22.55%
0.01
57.61%
0.11
1,332.37%
0.11
3.06%
0.06
45.18%
0.15
131.65%
0.15
4.27%
0.17
12.29%
0.13
20.84%
interest coverage
1.84
-
4.27
132.09%
10.86
154.13%
4.36
59.85%
5.31
21.68%
7.66
44.29%
55.50
624.82%
23.04
58.48%
10.10
56.17%
9.27
8.18%
interest debt per share
0.40
-
0.45
12.65%
0.85
87.58%
1.53
81.03%
1.68
9.49%
1.13
32.64%
0.91
19.84%
4.52
398.68%
5.31
17.55%
5.24
1.33%
inventory turnover
19.66
-
17.11
12.92%
12.53
26.77%
16.55
32.02%
16.30
1.48%
15.39
5.56%
11.40
25.95%
7.01
38.53%
6.24
10.95%
7.56
21.10%
invested capital
0.73
-
1.25
71.09%
0.35
71.75%
0.65
83.86%
0.61
6.66%
0.13
78.02%
0.12
11.30%
0.52
340.16%
0.58
11.13%
0.73
25.15%
market cap
2.48B
-
2.48B
0%
3.72B
50%
4.35B
17.11%
4.34B
0.21%
22.70B
422.82%
63.47B
179.63%
74.56B
17.47%
53.60B
28.11%
51.37B
4.17%
net current asset value
-331.92M
-
-571.11M
72.06%
56.01M
109.81%
-830.71M
1,583.09%
-1.00B
20.73%
3.85B
483.63%
2.57B
33.32%
549.68M
78.57%
-3.12B
666.99%
-1.97B
36.71%
net debt to ebitda
1.51
-
0.72
52.63%
0.48
33.38%
2.04
328.37%
1.56
23.54%
-3.34
313.61%
-1.16
65.26%
0.67
157.78%
1.77
163.53%
1.40
20.74%
net income per share
0.04
-
0.15
251.73%
0.23
59.71%
0.26
11.43%
0.38
47.25%
0.55
44.25%
0.99
78.96%
1.40
41.53%
1.16
16.89%
0.90
22.30%
operating cash flow per share
0.02
-
0.43
1,687.77%
0.31
27.55%
0.62
100.00%
0.83
33.79%
0.95
13.85%
1.39
46.71%
1.73
24.70%
1.81
4.56%
1.58
12.73%
payables turnover
22.05
-
19.71
10.62%
18.92
4.02%
16.84
11.00%
18.14
7.75%
20.54
13.19%
16.76
18.37%
15.10
9.92%
15.99
5.89%
18.57
16.12%
receivables turnover
3.23
-
4.07
26.30%
3.57
12.33%
3.88
8.74%
3.97
2.11%
3.63
8.37%
4.06
11.79%
4.76
17.08%
4.40
7.46%
3.81
13.46%
research and ddevelopement to revenue
0.01
-
0.01
10.30%
0.02
53.95%
0.02
22.63%
0.02
0.64%
0.03
34.87%
0.04
32.88%
return on tangible assets
0.02
-
0.06
177.42%
0.06
0.74%
0.07
4.24%
0.08
24.98%
0.06
29.05%
0.12
96.04%
0.11
7.58%
0.08
24.07%
0.07
13.55%
revenue per share
1.56
-
2.23
42.71%
2.16
3.42%
2.58
19.87%
3.28
27.03%
3.79
15.54%
4.33
14.13%
6.27
44.85%
8.68
38.50%
6.46
25.56%
roe
0.08
-
0.44
439.28%
0.10
77.12%
0.12
15.19%
0.15
26.04%
0.07
51.63%
0.13
87.61%
0.16
24.07%
0.13
20.53%
0.13
2.15%
roic
0.04
-
0.16
305.70%
0.07
59.55%
0.06
0.89%
0.08
27.28%
0.06
28.31%
0.11
92.04%
0.10
9.20%
0.08
23.88%
0.07
16.94%
sales general and administrative to revenue
0.18
-
0.10
45.24%
0.08
23.94%
0.06
26.60%
0.04
20.50%
0.06
34.26%
0.06
2.72%
0.03
40.56%
0.07
110.39%
0.07
8.84%
shareholders equity per share
0.51
-
0.33
34.78%
2.33
597.98%
2.25
3.27%
2.63
16.82%
7.84
198.25%
7.48
4.61%
8.53
14.07%
8.92
4.58%
7.08
20.59%
stock based compensation to revenue
0.01
-
-0.17
-
tangible asset value
236.23M
-
146.93M
37.80%
1.74B
1,085.35%
1.57B
9.58%
1.81B
15.07%
7.21B
298.10%
7.20B
0.18%
7.51B
4.23%
7.35B
2.09%
10.06B
36.88%
tangible book value per share
0.47
-
0.29
37.80%
2.30
690.23%
1.77
22.79%
2.05
15.31%
7.28
256.02%
6.07
16.62%
6.32
4.12%
6.22
1.67%
5.68
8.69%
working capital
-239.26M
-
-530.11M
121.56%
436.28M
182.30%
137.16M
68.56%
24.85M
81.88%
4.67B
18,710.94%
3.56B
23.88%
5.66B
59.09%
2.62B
53.66%
7.22B
175.19%

All numbers in (except ratios and percentages)